Clarity signs a Commercial Manufacturing Agreement
Filed with ASX · · 3 pages · English
Clarity Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Clarity Pharmaceuticals
- Co-PSMA data published in the European Urology journal
- Clarity signs a large-scale Manufacturing Supply Agreement for copper-64 with Theragenics
- Clarity signs a large-scale Manufacturing Supply Agreement
- Co-PSMA data presented at EAU Annual Congress 2026 with manuscript accepted for publication in the European Urology journal
- Co-PSMA data presented
Later from Clarity Pharmaceuticals
- Clarity signs a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with Nucleus RadioPharma
- Clarity receives $9.8 million R&D tax incentive refund
- Data on SAR-bisPSMA to be presented at EANM
- Becoming a substantial holder
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Clarity Pharmaceuticals into a list and get an email when it puts out news.
Follow Clarity Pharmaceuticals